Roche pharmacovigilance inquiry - ball now in EC's court
This article was originally published in Scrip
Executive Summary
The EMA has completed its inquiry into allegations that Roche failed to comply with its pharmacovigilance obligations regarding its 19 centrally authorized medicines, and has sent a report outlining its conclusions to the European Commission.